
Tempest Therapeutics, Inc.
TPSTNasdaqCIK 1544227HealthcareFiscal year ends Dec 31
Reports and events: 308 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-12-2916:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-314745 |
| 2022-11-0809:02 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001544227-22-000006 |
| 2022-11-0808:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001544227-22-000004 |
| 2022-09-2316:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-250135 |
| 2022-08-1508:10 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628280-22-022788 |
| 2022-08-1508:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-022786 |
| 2022-06-2107:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-177053 |
| 2022-06-0908:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-170659 |
| 2022-05-2617:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-161149 |
| 2022-05-1308:04 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001628280-22-014231 |
| 2022-05-1308:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-014229 |
| 2022-05-0917:26 ET | SC 13D | Ownership report, active investor | 0001193125-22-145151 |
| 2022-05-0216:05 ET | DEF 14A | Proxy statementPeriod 2022-06-17 | 0001193125-22-136738 |
| 2022-05-0208:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-135401 |
| 2022-04-0121:43 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001193125-22-092417 |
| 2022-03-2916:57 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001628280-22-007717 |
| 2022-03-2916:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-007714 |
| 2021-12-2316:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-21-025555 |
| 2021-11-1016:07 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001628280-21-022803 |
| 2021-11-1015:54 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-022785 |
| 2021-09-3010:47 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-21-287569 |
| 2021-09-2411:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-21-281694 |
| 2021-08-1216:27 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-244745 |
| 2021-08-1216:23 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-244725 |
| 2021-07-2317:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-223143 |
| 2021-07-1616:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-217458 |
| 2021-07-1208:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-212534 |
| 2021-07-0717:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-209988 |
| 2021-07-0116:44 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-21-206427 |
| 2021-06-2808:51 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-201157 |
| 2021-06-2321:10 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-196512 |
| 2021-06-1117:21 ET | 8-K | 8.01 Other events | 0001193125-21-189024 |
| 2021-05-1307:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001544227-21-000029 |
| 2021-04-2916:09 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001544227-21-000026 |
| 2021-04-1310:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-21-000364 |
| 2021-03-2907:38 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001544227-21-000018 |
| 2021-03-2907:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-042768 |
| 2021-01-2808:01 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001544227-21-000005 |
| 2021-01-0509:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-000639 |
| 2020-11-0907:01 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001544227-20-000045 |
| 2020-09-2408:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001544227-20-000042 |
| 2020-08-1007:01 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001544227-20-000039 |
| 2020-07-3011:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-20-088216 |
| 2020-06-2308:36 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-075873 |
| 2020-05-0807:36 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001544227-20-000014 |
| 2020-04-2414:59 ET | DEF 14A | Proxy statementPeriod 2020-06-19 | 0001544227-20-000008 |
| 2020-04-0607:16 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-043387 |
| 2020-03-1106:39 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001544227-20-000004 |
| 2020-03-0408:37 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-028925 |
| 2020-02-1008:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-012871 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.